Accu-Stat Medical Transcription is categorized under Medical Transcription Services in Albuquerque, NM and active since 1993.
Accu-Stat Medical Transcription was established in 1993, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Medical Transcription Services business, which does work in the B2B market, and is classified as a Medical Transcription Services, under code number by the NAICS.
If you are seeking more information, feel free to contact Lyle Pino at the company’s single location by writing to Albuquerque, Albuquerque, New Mexico NM 87109 or by phoning (505) 828-4432. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Accu-Stat Medical Transcription |
Contact Person: | Lyle Pino |
Address: | Albuquerque, Albuquerque, New Mexico 87109 |
Phone Number: | (505) 828-4432 |
Website Address: | accustat.org |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 1993 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Medical Transcription Services |
Share This Business: |
Accu-Stat Medical Transcription was started in 1993 to provide professional Medical Transcription Services under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Lyle Pino for inquiries that concern Accu-Stat Medical Transcription by calling the company number (505) 828-4432, as your correspondence is most welcome. Additionally, the physical location of the single location of Accu-Stat Medical Transcription can be found at the coordinates 35.14915,-106.57334 as well as the street address Albuquerque in Albuquerque, New Mexico 87109.
For its online presence, you may visit Accu-Stat Medical Transcription’s website at accustat.org and engage with its social media outlets through on Twitter and on Facebook.